AKT1 and angiosarcoma: Phosphatidylinositol-3 kinase-Akt pathways are shown to be activated in angiosarcoma; however, no comprehensive studies have been conducted for elucidating the molecular etiology of the diseases.43 No therapeutic intervention has been developed for the treatment of angiosarcoma.